It has been reported that elevated COX-2 levels predicted poorer survival of non-small cell lung cancer (14), and higher COX-2 expression was significantly associated with histological type, lymph node metastasis, and venous invasion of liver cancer (15). This evidence concerns the gene PTGS2 and metastatic malignant neoplasm in the lymph nodes.